Transcription antiterminators - Revision history

Jstuelk: /* Transcription antiterminators controlled by PTS-dependent phosphorylation */

2011-12-05T13:58:03Z

‎Transcription antiterminators controlled by PTS-dependent phosphorylation

Jstuelk at 13:57, 5 December 2011

2011-12-05T13:57:41Z

Jstuelk: /* Transcription antiterminators controlled by low molecular weight effectors */

2009-11-17T22:56:26Z

‎Transcription antiterminators controlled by low molecular weight effectors

Jstuelk at 22:54, 17 November 2009

2009-11-17T22:54:28Z

Jstuelk: Created page with '==Transcription antiterminators controlled by PTS-dependent phosphorylation== These proteins exert positive control of gene expression by transcription antitermination. They regu…'

2009-08-31T20:11:30Z

Created page with '==Transcription antiterminators controlled by PTS-dependent phosphorylation== These proteins exert positive control of gene expression by transcription antitermination. They regu…'

New page

==Transcription antiterminators controlled by PTS-dependent phosphorylation==
These proteins exert positive control of gene expression by transcription antitermination. They regulate the uptake and utilization of specific sugars that are transported by the phosphotransferase system (PTS).
Their activity is negatively regulated in the absence of the specific inducer by phosphorylation by the corresponding Enzyme II of the PTS. This results in their inactivity. In the presence of the inducer, the phosphate group is drained to the transported substrate and the active regulators lead to expression of their corresponding catabolic operons.
In addition, many PRD-containing regulators are positively controlled by [[PtsH|HPr]]-dependent phosphorylation. This phosphorylation occurs in the absence of glucose and other preferred carbon sources and is part of catabolite repression.

* [[GlcT]]: allows expression of the ''[[ptsG]]-[[ptsH]]-[[ptsI]]'' operon in the presence of glucose
* [[LicT]]: allows expression of the ''[[bglS]]'' gene and the ''[[bglP]]-[[bglH]]'' operon in the presence of ß-glucosides
* [[SacT]]: allows expression of the ''[[sacP]]-[[sacA]]'' operon in the presence of sucrose
* [[SacY]]: allows expression of the ''[[sacX]]-[[sacY]]'' operon and the ''[[sacB]]'' gene in the presence of sucrose

* Reviews
<pubmed>9663674,11751049 </pubmed>

==Transcription antiterminators controlled by low molecular weight effectors==
* [[GlpP]]

@@ Line 13: / Line 13: @@
 * [[GlpP]]
 * [[HutP]]
 ==Reviews==
 <pubmed>9663674,11751049 9044276 12029388  </pubmed>

@@ Line 2: / Line 2: @@
 These proteins exert positive control of gene expression by transcription antitermination. They regulate the uptake and utilization of specific sugars that are transported by the phosphotransferase system ([[PTS]]).
 Their activity is negatively regulated in the absence of the specific inducer by phosphorylation by the corresponding Enzyme II of the [[PTS]]. This results in their inactivity. In the presence of the inducer, the phosphate group is drained to the transported substrate and the active regulators lead to expression of their corresponding catabolic operons.
-In addition, many [[PRD-containing regulators]] are positively controlled by [[PtsH|HPr]]-dependent phosphorylation. This phosphorylation occurs in the absence of glucose and other preferred carbon sources and is part of catabolite repression.
+In addition, many PRD-containing regulators are positively controlled by [[PtsH|HPr]]-dependent phosphorylation. This phosphorylation occurs in the absence of glucose and other preferred carbon sources and is part of catabolite repression.
 * [[GlcT]]: allows expression of the ''[[ptsG]]-[[ptsH]]-[[ptsI]]'' operon in the presence of glucose
@@ Line 8: / Line 8: @@
 * [[SacT]]: allows expression of the ''[[sacP]]-[[sacA]]'' operon in the presence of sucrose
 * [[SacY]]: allows expression of the ''[[sacX]]-[[sacY]]'' operon and the ''[[sacB]]'' gene in the presence of sucrose
 ==Transcription antiterminators controlled by low molecular weight effectors==